https://www.bloomberg.com/authors/AOT-PES_YEg/ryan-flinnhttps://www.bloomberg.com/feeds/static/images/bloomberg_logo_black.pnghttps://www.bloomberg.com/authors/AOT-PES_YEg/ryan-flinnRSS for NodeMon, 20 Apr 2026 20:12:10 GMThttps://www.bloomberg.com/news/articles/2013-05-22/biomarin-gains-on-prospects-for-experimental-cancer-drughttps://www.bloomberg.com/news/articles/2013-05-22/biomarin-gains-on-prospects-for-experimental-cancer-drugWed, 22 May 2013 18:39:37 GMThttps://www.bloomberg.com/news/articles/2013-05-09/dendreon-falls-as-provenge-sales-miss-analysts-estimateshttps://www.bloomberg.com/news/articles/2013-05-09/dendreon-falls-as-provenge-sales-miss-analysts-estimatesThu, 09 May 2013 20:09:18 GMThttps://www.bloomberg.com/news/articles/2013-05-03/gilead-rises-to-highest-price-on-potential-drug-saleshttps://www.bloomberg.com/news/articles/2013-05-03/gilead-rises-to-highest-price-on-potential-drug-salesFri, 03 May 2013 20:18:10 GMThttps://www.bloomberg.com/news/articles/2013-05-02/health-management-says-u-s-issued-subpoena-on-paymentshttps://www.bloomberg.com/news/articles/2013-05-02/health-management-says-u-s-issued-subpoena-on-paymentsFri, 03 May 2013 20:13:16 GMThttps://www.bloomberg.com/news/articles/2013-05-02/arena-withdrawing-obesity-drug-regulatory-application-in-europehttps://www.bloomberg.com/news/articles/2013-05-02/arena-withdrawing-obesity-drug-regulatory-application-in-europeThu, 02 May 2013 21:12:39 GMThttps://www.bloomberg.com/news/articles/2013-05-02/gilead-misses-analysts-estimates-on-sales-of-hiv-drugshttps://www.bloomberg.com/news/articles/2013-05-02/gilead-misses-analysts-estimates-on-sales-of-hiv-drugsThu, 02 May 2013 20:22:25 GMThttps://www.bloomberg.com/news/articles/2013-05-02/gilead-s-hepatitis-c-treatment-clears-virus-in-eight-weeks-1-https://www.bloomberg.com/news/articles/2013-05-02/gilead-s-hepatitis-c-treatment-clears-virus-in-eight-weeks-1-Thu, 02 May 2013 20:21:01 GMThttps://www.bloomberg.com/news/articles/2013-05-01/medicaid-expansion-may-not-improve-health-of-poor-in-u-s-https://www.bloomberg.com/news/articles/2013-05-01/medicaid-expansion-may-not-improve-health-of-poor-in-u-s-Thu, 02 May 2013 04:01:00 GMThttps://www.bloomberg.com/news/articles/2013-04-30/actavis-seen-selling-for-higher-valuation-real-m-ahttps://www.bloomberg.com/news/articles/2013-04-30/actavis-seen-selling-for-higher-valuation-real-m-aWed, 01 May 2013 20:12:46 GMThttps://www.bloomberg.com/news/articles/2013-04-27/valeant-in-talks-with-actavis-on-merger-of-generic-drug-makershttps://www.bloomberg.com/news/articles/2013-04-27/valeant-in-talks-with-actavis-on-merger-of-generic-drug-makersSat, 27 Apr 2013 04:00:01 GMThttps://www.bloomberg.com/news/articles/2013-04-25/ancient-mayan-culture-created-from-many-influences-study-findshttps://www.bloomberg.com/news/articles/2013-04-25/ancient-mayan-culture-created-from-many-influences-study-findsThu, 25 Apr 2013 14:00:00 GMThttps://www.bloomberg.com/news/articles/2013-04-23/amgen-tops-analyst-estimates-as-profit-benefits-from-tax-credithttps://www.bloomberg.com/news/articles/2013-04-23/amgen-tops-analyst-estimates-as-profit-benefits-from-tax-creditWed, 24 Apr 2013 20:14:52 GMThttps://www.bloomberg.com/news/articles/2013-04-22/chili-peppers-seen-helping-36-million-migraine-sufferershttps://www.bloomberg.com/news/articles/2013-04-22/chili-peppers-seen-helping-36-million-migraine-sufferersMon, 22 Apr 2013 20:07:54 GMThttps://www.bloomberg.com/news/articles/2013-04-16/allergan-s-migraine-drug-inhaler-levadex-rejectedhttps://www.bloomberg.com/news/articles/2013-04-16/allergan-s-migraine-drug-inhaler-levadex-rejectedTue, 16 Apr 2013 20:11:21 GMThttps://www.bloomberg.com/news/articles/2013-04-03/dementia-care-more-expensive-than-heart-disease-study-sayshttps://www.bloomberg.com/news/articles/2013-04-03/dementia-care-more-expensive-than-heart-disease-study-saysThu, 04 Apr 2013 04:00:00 GMThttps://www.bloomberg.com/news/articles/2013-03-28/gilead-hits-record-high-on-analyst-s-view-of-higher-saleshttps://www.bloomberg.com/news/articles/2013-03-28/gilead-hits-record-high-on-analyst-s-view-of-higher-salesThu, 28 Mar 2013 20:06:15 GMThttps://www.bloomberg.com/news/articles/2013-03-20/arena-joins-vivus-finding-obesity-drugs-fizzle-on-costshttps://www.bloomberg.com/news/articles/2013-03-20/arena-joins-vivus-finding-obesity-drugs-fizzle-on-costsWed, 20 Mar 2013 20:15:47 GMThttps://www.bloomberg.com/news/articles/2013-03-18/affymax-fires-75-of-workers-while-considering-closurehttps://www.bloomberg.com/news/articles/2013-03-18/affymax-fires-75-of-workers-while-considering-closureTue, 19 Mar 2013 20:11:38 GMThttps://www.bloomberg.com/news/articles/2013-03-19/nps-buys-back-rights-to-gattex-from-takeda-to-spur-saleshttps://www.bloomberg.com/news/articles/2013-03-19/nps-buys-back-rights-to-gattex-from-takeda-to-spur-salesTue, 19 Mar 2013 20:10:12 GMThttps://www.bloomberg.com/news/articles/2013-03-12/nasa-says-mars-rover-finds-conditions-once-suited-for-lifehttps://www.bloomberg.com/news/articles/2013-03-12/nasa-says-mars-rover-finds-conditions-once-suited-for-lifeWed, 13 Mar 2013 04:01:00 GMT